Health-related quality of life in older patients with HER2+ metastatic breast cancer: Comparing pertuzumab plus trastuzumab with or without metronomic chemotherapy in a randomised open-label phase II clinical trial

Lissandra Dal Lago, Aimé Lambert Uwimana, Corneel Coens, Peter Vuylsteke, Giuseppe Curigliano, Barbara Brouwers, Agnieszka Jagiello-Gruszfeld, Sevilay Altintas, Konstantinos Tryfonidis, Coralie Poncet, Andrew Bottomley, Berta Sousa, Etienne Brain, Hans Wildiers. Published:January 28, 2022 DOI:https://doi.org/10.1016/j.jgo.2022.01.009